Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Labetalol, Magnesium Sulfate or Lidocaine Infusion on Opioid Consumption During Laparoscopic Cholecystectomy
NCT07865455Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2026
- Primary completion
- Nov 2027
01
Overview
Phase 4, randomised trial in postoperative pain comparing Group Lb: Labetalol Infusion, Group M: Magnesium Sulfate Infusion and Group L: Lidocaine Infusion (3 arms). Primary endpoint: Total 24-Hour Opioid Consumption. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
labetalolmagnesium sulfateLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT07865455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07865455.